Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

FENTANYL 50 MCG/HR PATCH

Fentanyl
$9.3957per EA
DEA Schedule CII

Strength

50 ug/1

Manufacturer

Alvogen Inc.

NDC

47781042647

Classification

Generic

Dosage Form

PATCH

Route

TRANSDERMAL

Last Updated

4/22/2026

Active Ingredients

FENTANYL

Approval Type

Generic (ANDA)

FDA Application

ANDA202097

On Market Since

11/4/2016

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price History

1W

0.0%

1M

+0.2%

3M

-1.8%

6M

-1.4%

1Y

-4.7%

3Y

+9.8%

5Y

+80.6%

All

+64.8%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

TRAMADOL HCL 50 MG TABLET
Generic
00093005805•Teva Pharmaceuticals USA Inc.
$0.0239
per EA
TRAMADOL HCL 50 MG TABLET
Generic
00093330101•Teva Pharmaceuticals USA Inc.
$0.0241
per EA
TRAMADOL HCL 50 MG TABLET
Generic
00093330105•Teva Pharmaceuticals USA Inc.
$0.0241
per EA
TRAMADOL HCL 50 MG TABLET
Generic
00904749661•Major Pharmaceuticals
$0.0241
per EA
TRAMADOL HCL 50 MG TABLET
Generic
16571071601•Rising Pharma Holdings Inc.
$0.0241
per EA
TRAMADOL HCL 50 MG TABLET
Generic
16571071610•Rising Pharma Holdings Inc.
$0.0241
per EA
TRAMADOL HCL 50 MG TABLET
Generic
16571071650•Rising Pharma Holdings Inc.
$0.0241
per EA
TRAMADOL HCL 50 MG TABLET
Generic
29300035501•Unichem Pharmaceuticals (USA) Inc.
$0.0241
per EA
TRAMADOL HCL 50 MG TABLET
Generic
29300035505•Unichem Pharmaceuticals (USA) Inc.
$0.0241
per EA
TRAMADOL HCL 50 MG TABLET
Generic
29300035510•Unichem Pharmaceuticals (USA) Inc.
$0.0241
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy